Wong GLH - Search Results

1

Loss of tumor suppressor IGFBP4 drives epigenetic reprogramming in hepatic carcinogenesis.

Lee YY, Mok MT, Kang W, Yang W, Tang W, Wu F, Xu L, Yan M, Yu Z, Lee SD, Tong JHM, Cheung YS, Lai PBS, Yu DY, Wang Q, Wong GLH, Chan AM, Yip KY, To KF, Cheng ASL. Lee YY, et al. Among authors: wong glh. Nucleic Acids Res. 2018 Sep 28;46(17):8832-8847. doi: 10.1093/nar/gky589. Nucleic Acids Res. 2018. PMID: 29992318 Free PMC article.

2

Evaluation of model for end stage liver disease (MELD)-based systems as prognostic index for hepatocellular carcinoma.

Limquiaco JL, Wong GL, Wong VW, Lai PB, Chan HL. Limquiaco JL, et al. J Gastroenterol Hepatol. 2009 Jan;24(1):63-9. doi: 10.1111/j.1440-1746.2008.05701.x. Epub 2008 Nov 26. J Gastroenterol Hepatol. 2009. PMID: 19054256

3

Lamivudine monoprophylaxis and adefovir salvage for liver transplantation in chronic hepatitis B: a seven-year follow-up study.

Limquiaco JL, Wong J, Wong VW, Wong GL, Tse CH, Chan HY, Kwan KY, Lai PB, Chan HL. Limquiaco JL, et al. J Med Virol. 2009 Feb;81(2):224-9. doi: 10.1002/jmv.21369. J Med Virol. 2009. PMID: 19107976

4

Repeat-screening colonoscopy 5 years after normal baseline-screening colonoscopy in average-risk Chinese: a prospective study.

Leung WK, Lau JY, Suen BY, Wong GL, Chow DK, Lai LH, To KF, Yim CK, Lee ES, Tsoi KK, Ng SS, Sung JJ. Leung WK, et al. Am J Gastroenterol. 2009 Aug;104(8):2028-34. doi: 10.1038/ajg.2009.202. Epub 2009 May 19. Am J Gastroenterol. 2009. PMID: 19455125

5

Meta-analysis: the efficacy of anti-viral therapy in prevention of recurrence after curative treatment of chronic hepatitis B-related hepatocellular carcinoma.

Wong JS, Wong GL, Tsoi KK, Wong VW, Cheung SY, Chong CN, Wong J, Lee KF, Lai PB, Chan HL. Wong JS, et al. Aliment Pharmacol Ther. 2011 May;33(10):1104-12. doi: 10.1111/j.1365-2036.2011.04634.x. Epub 2011 Mar 24. Aliment Pharmacol Ther. 2011. PMID: 21488914 Free article.

6

Non-invasive algorithms for liver fibrosis.

Yu Z, Wong VW, Wong GL. Yu Z, et al. Aliment Pharmacol Ther. 2012 Jan;35(2):310-1; discussion 311-3. doi: 10.1111/j.1365-2036.2011.04933.x. Aliment Pharmacol Ther. 2012. PMID: 22172082 Free article. No abstract available.

7

Commentary: time to update the ALT cut-off?

Yu Z, Wong GL, Wong VW. Yu Z, et al. Aliment Pharmacol Ther. 2012 Oct;36(7):682-3. doi: 10.1111/apt.12022. Aliment Pharmacol Ther. 2012. PMID: 22966796 Free article. No abstract available.

8

Evaluation of histological staging systems for primary biliary cirrhosis: correlation with clinical and biochemical factors and significance of pathological parameters in prognostication.

Chan AW, Chan RC, Wong GL, Wong VW, Choi PC, Chan HL, To KF. Chan AW, et al. Histopathology. 2014 Aug;65(2):174-86. doi: 10.1111/his.12384. Epub 2014 Mar 14. Histopathology. 2014. PMID: 24479738

9

Antiviral therapy improves post-hepatectomy survival in patients with hepatitis B virus-related hepatocellular carcinoma: a prospective-retrospective study.

Chong CC, Wong GL, Wong VW, Ip PC, Cheung YS, Wong J, Lee KF, Lai PB, Chan HL. Chong CC, et al. Aliment Pharmacol Ther. 2015 Jan;41(2):199-208. doi: 10.1111/apt.13034. Epub 2014 Nov 21. Aliment Pharmacol Ther. 2015. PMID: 25413146 Free article.

10

Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients.

Jiang P, Chan CW, Chan KC, Cheng SH, Wong J, Wong VW, Wong GL, Chan SL, Mok TS, Chan HL, Lai PB, Chiu RW, Lo YM. Jiang P, et al. Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):E1317-25. doi: 10.1073/pnas.1500076112. Epub 2015 Feb 2. Proc Natl Acad Sci U S A. 2015. PMID: 25646427 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

446 results

Search Page